Abstract:Introduction: The overall combined prevalence of anxiety and depression in patients with epilepsy has been estimated at 20.2 and 22.9%, respectively, and is considered more severe in drug-refractory epilepsy. Patients admitted to epilepsy monitoring units constitute a particular group. Also, patients with psychogenic non-epileptic seizures can reach more than 20% of all admissions. This study aims to characterize these symptoms in a large cohort of patients admitted for evaluation in a tertiary epilepsy center… Show more
“…These psychiatric comorbidities are associated with increased adverse reactions related to ASM 25 . There are reports of depression and anxiety independently affecting QOL in PWE 22,26,27 . We found significant negative associations between depressive and anxious symptoms and QOL in PWE (Figure 1Ab,c,Bb,c) similar to those of Johnson et al 9 …”
Section: Discussionsupporting
confidence: 83%
“…25 There are reports of depression and anxiety independently affecting QOL in PWE. 22,26,27 We found significant negative associations between depressive and anxious symptoms and QOL in PWE (Figure 1Ab,c,Bb,c) similar to those of Johnson et al 9 Stress can be a precipitating factor for developing seizures. However, reports are scanty on the effect of subjective stress on QOL in epilepsy.…”
ObjectivesWe assessed the quality of life, sleep, depression, anxiety, and stress in people with pharmacoresistant epilepsy (PRE) and newly diagnosed epilepsy (NDE). We also assessed the influence of sleep, depression, anxiety, and stress on the quality of life (QOL) and the complex association between these factors.MethodsWe recruited 80 PRE and 70 NDE people attending the epilepsy clinic. We assessed QOL, sleep quality, daytime sleepiness, and mood using the quality of life in epilepsy‐31 inventory (QOLIE‐31), Pittsburgh sleep quality index (PSQI), Epworth sleepiness scale (ESS), and depression anxiety stress scale (DASS‐21). We compared the results between the two groups of epilepsy populations. We performed univariate and multivariate linear regression to determine the factors affecting the QOLIE‐31 total score. We applied Spearman's rank correlation to find the interrelationship between variables influencing QOL.ResultsWe found significantly lower QOLIE‐31 total scores (p = .001) in PRE compared to NDE. The PSQI and ESS did not differ significantly between the PRE and NDE groups. Anxiety (p = .002) and stress (p = .003) scores were significantly higher in PRE than in NDE. QOLIE‐31 total scores showed a negative correlation with PSQI as well as symptoms of depression, anxiety, and stress scores in both groups. Multiple linear regression analysis revealed depression as a major factor influencing the QOLIE‐31 total score in PRE (p = .001) and NDE (p = .003). We found significant complex associations between PSQI, depression, anxiety, stress, and QOLIE total scores in both groups.SignificanceThe QOL is poorer for people with PRE than for those with NDE. Depression is a major determinant of QOL in PWE. These factors need to be considered to improve the QOL in epilepsy.
“…These psychiatric comorbidities are associated with increased adverse reactions related to ASM 25 . There are reports of depression and anxiety independently affecting QOL in PWE 22,26,27 . We found significant negative associations between depressive and anxious symptoms and QOL in PWE (Figure 1Ab,c,Bb,c) similar to those of Johnson et al 9 …”
Section: Discussionsupporting
confidence: 83%
“…25 There are reports of depression and anxiety independently affecting QOL in PWE. 22,26,27 We found significant negative associations between depressive and anxious symptoms and QOL in PWE (Figure 1Ab,c,Bb,c) similar to those of Johnson et al 9 Stress can be a precipitating factor for developing seizures. However, reports are scanty on the effect of subjective stress on QOL in epilepsy.…”
ObjectivesWe assessed the quality of life, sleep, depression, anxiety, and stress in people with pharmacoresistant epilepsy (PRE) and newly diagnosed epilepsy (NDE). We also assessed the influence of sleep, depression, anxiety, and stress on the quality of life (QOL) and the complex association between these factors.MethodsWe recruited 80 PRE and 70 NDE people attending the epilepsy clinic. We assessed QOL, sleep quality, daytime sleepiness, and mood using the quality of life in epilepsy‐31 inventory (QOLIE‐31), Pittsburgh sleep quality index (PSQI), Epworth sleepiness scale (ESS), and depression anxiety stress scale (DASS‐21). We compared the results between the two groups of epilepsy populations. We performed univariate and multivariate linear regression to determine the factors affecting the QOLIE‐31 total score. We applied Spearman's rank correlation to find the interrelationship between variables influencing QOL.ResultsWe found significantly lower QOLIE‐31 total scores (p = .001) in PRE compared to NDE. The PSQI and ESS did not differ significantly between the PRE and NDE groups. Anxiety (p = .002) and stress (p = .003) scores were significantly higher in PRE than in NDE. QOLIE‐31 total scores showed a negative correlation with PSQI as well as symptoms of depression, anxiety, and stress scores in both groups. Multiple linear regression analysis revealed depression as a major factor influencing the QOLIE‐31 total score in PRE (p = .001) and NDE (p = .003). We found significant complex associations between PSQI, depression, anxiety, stress, and QOLIE total scores in both groups.SignificanceThe QOL is poorer for people with PRE than for those with NDE. Depression is a major determinant of QOL in PWE. These factors need to be considered to improve the QOL in epilepsy.
“…Available literature data indicate that psychiatric disorders occur in a higher percentage in PWE than in the general population with an increased risk of 2 to 5-fold [ 1 , 4 , 27 - 29 ]. One out of three PWE has a diagnosis of a psychiatric disorder over lifetime [ 4 ].…”
Section: Epidemiology Of Psychiatric Disorders In Patients With Epilepsymentioning
confidence: 99%
“…In another review, anxiety was more prevalent than depressive symptoms (44.8-52.9% vs . 30.8-49.9%) [ 29 ]. High prevalence values have been also reported for sleep disturbances, especially insomnia (61.4%) followed by excessive daytime sleepiness (EDS) and restless leg syndrome (RLS) (35.7% and 28.6%, respectively) [ 34 ].…”
Section: Epidemiology Of Psychiatric Disorders In Patients With Epilepsymentioning
Psychiatric disorder comorbidity in patients with epilepsy (PWE) is very frequent with a mean percentage prevalence of up to 50% and even higher. Such a high frequency suggests that epilepsy and psychiatric disorders might share common pathological pathways. Various aspects contribute to make the matter very complex from a therapeutic point of view. Some antiseizure medications (ASMs), namely valproic acid, carbamazepine and lamotrigine, have mood-stabilising effects and are routinely used for the treatment of bipolar disorder in patients who do not have epilepsy. Gabapentin and especially pregabalin exert anxiolytic effects. However, a number of ASMs, in particular levetiracetam, topiramate, and perampanel, may contribute to psychiatric disorders, including depression, aggressive behaviour and even psychosis. If these ASMs are prescribed, the patient should be monitored closely. A careful selection should be made also with psychotropic drugs. Although most of these can be safely used at therapeutic doses, bupropion, some tricyclic antidepressants, maprotiline, and clozapine may alter seizure threshold and facilitate epileptic seizures. Interactions between ASMs and psychotropic medication may make it difficult to predict individual response. Pharmacokinetic interactions can be assessed with drug monitoring and are consequently much better documented than pharmacodynamic interactions. Another aspect that needs a careful evaluation is patient adherence to treatment. Prevalence of non-adherence in PWE and psychiatric comorbidities is reported to reach values even higher than 70%. A careful evaluation of all these aspects contributes to optimize therapy with positive impact on seizure control, psychiatric wellbeing and quality of life.
“…Epilepsy often causes physical and psychological harm to patients, such as sudden unexpected death in epilepsy, status epileptics, falls, sleep disorder, social maladjustment, etc ( 4 – 10 ). These symptoms have seriously affected epilepsy patients' quality of life ( 11 ), thereby resulting in a Self-Perceived Burden (SPB). Adults are the backbone of the family and society, and adult epilepsy patients need to bear greater psychological, emotional, economic and social pressure than minors and elderly patients and are more likely to develop SPB.…”
ObjectivesEpilepsy requires long-term or lifelong treatment, and patients are prone to financial, emotional and psychological burdens that can cause psychological changes during the treatment process. This study aimed to describe the prevalence and associated factors of Self-Perceived Burden (SPB) in Chinese adult epilepsy patients, informing the treatment and nursing of epilepsy.MethodsA total of 143 adult epilepsy patients were included in this study, and the clinical questionnaire survey was conducted at the Third Xiangya Hospital of Central South University in Hunan, China, from March 2022 to June 2022. The sociodemographic and clinical characteristics of adult epilepsy patients were collected using a self-developed questionnaire, and the data on SPB, stigma and quality of life were collected through the Self-Perceived Burden Scale (SPBS), Kilifi Stigma Scale for Epilepsy (KSSE) and Quality of Life in Epilepsy Inventory-31 (QOLIE-31). Multiple linear regression analysis was used to determine the associated factors influencing SPB in adult epilepsy patients.ResultsThe average score of SPBS for the 143 adult epilepsy patients was 30.77 (SD = 9.06), and 89.5% of them had obvious SPB. The results of the univariate analysis showed that residence, monthly household income, duration of epilepsy, type of medication and electroencephalogram finding were associated with SPB (P < 0.05). In Spearman correlation analysis indicated that SPBS score were positively correlated with KSSE score (r = 0.510, P < 0.05) while negatively correlated with QOLIE-31 score (r = −0.506, P < 0.05). Multiple linear regression analysis revealed that factors such as KSSE, type of medication, residence and electroencephalogram finding accounted for 32.8% of the factors influencing SPB in adult epilepsy patients.Conclusion89.5% of adult epilepsy patients have varying degrees of SPB, which is associated with high stigma and poor quality of life. Therefore, during the treatment and nursing of adult epilepsy patients, clinical staff should pay attention to the psychological status of patients, help them reduce their psychological burden, and guide them to develop a healthy lifestyle.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.